Skip to main content
Download PDF

Correction to: New paradigm for stage III melanoma: from surgery to adjuvant treatment

Journal of Translational Medicine volume 17, Article number: 315 (2019) Cite this article

The Original Article was published on 14 August 2019

Correction to: J Transl Med (2019) 17:266 https://doi.org/10.1186/s12967-019-2012-2

Following publication of the original article [1], the authors reported that one of the authors, Corrado Caracò, has been accidentally omitted from the author list. In this Correction the author has been added to the author list.

The correction has been implemented in the original publication of this article as well and the ‘Authors’ contributions’ section has been updated accordingly there.

Reference

  1. Ascierto PA, Borgognoni L, Botti G, Guida M, Marchetti P, Mocellin S, Muto P, Palmieri G, Patuzzo R, Quaglino P, Stanganelli I, Caracò C. New paradigm for stage III melanoma: from surgery to adjuvant treatment. J Transl Med. 2019;17:266. https://doi.org/10.1186/s12967-019-2012-2.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Unit Melanoma, Cancer Immunotherapy and Innovative Therapies, Istituto Nazionale Tumori IRCCS Fondazione “G. Pascale”, Naples, Italy

    Paolo Antonio Ascierto

  2. Ospedale Santa Maria Annunziata and University of Florence, Florence, Italy

    Lorenzo Borgognoni

  3. Istituto Nazionale Tumori IRCCS Fondazione “G. Pascale”, Naples, Italy

    Gerardo Botti, Paolo Muto & Corrado Caracò

  4. Unit Melanoma and Rare Tumors, IRCCS Istituto Tumori Giovanni Paolo II, Bari, Italy

    Michele Guida

  5. Oncologia Medica B Policlinico Umberto I di Roma, Rome, Italy

    Paolo Marchetti

  6. Surgical Oncology Unit, IOV-IRCCS of Padova and Dept. Surgery Oncology Gastroenterology, University of Padova, Padua, Italy

    Simone Mocellin

  7. Unit of Cancer Genetics, ICB-CNR, Sassari, Italy

    Giuseppe Palmieri

  8. Research Director CNR, Italian Melanoma Intergroup (IMI), Unit of Cancer Genetics, Head Institute of Biomolecular Chemistry (ICB), National Research Council (CNR), Sassari, Italy

    Giuseppe Palmieri

  9. IRCCS Fondazione Istituto Nazionale dei Tumori di Milano, Milan, Italy

    Roberto Patuzzo

  10. Dermatologic Clinic, Department of Medical Sciences, University of Turin Medical School, Turin, Italy

    Pietro Quaglino

  11. Skin Cancer Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST), IRCCS, Meldola, FC, Italy

    Ignazio Stanganelli

  12. University of Parma, Parma, Italy

    Ignazio Stanganelli

Authors
  1. Paolo Antonio Ascierto
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lorenzo Borgognoni
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gerardo Botti
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Michele Guida
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Paolo Marchetti
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Simone Mocellin
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Paolo Muto
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Giuseppe Palmieri
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Roberto Patuzzo
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Pietro Quaglino
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Ignazio Stanganelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Corrado Caracò
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Paolo Antonio Ascierto.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ascierto, P.A., Borgognoni, L., Botti, G. et al. Correction to: New paradigm for stage III melanoma: from surgery to adjuvant treatment. J Transl Med 17, 315 (2019). https://doi.org/10.1186/s12967-019-2067-0

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s12967-019-2067-0

Journal of Translational Medicine

ISSN: 1479-5876

Contact us